全文获取类型
收费全文 | 57641篇 |
免费 | 4577篇 |
国内免费 | 1719篇 |
专业分类
耳鼻咽喉 | 754篇 |
儿科学 | 685篇 |
妇产科学 | 632篇 |
基础医学 | 8054篇 |
口腔科学 | 1423篇 |
临床医学 | 5445篇 |
内科学 | 9721篇 |
皮肤病学 | 1794篇 |
神经病学 | 3841篇 |
特种医学 | 3429篇 |
外国民族医学 | 6篇 |
外科学 | 7694篇 |
综合类 | 4439篇 |
现状与发展 | 4篇 |
一般理论 | 8篇 |
预防医学 | 3323篇 |
眼科学 | 1015篇 |
药学 | 5496篇 |
32篇 | |
中国医学 | 1662篇 |
肿瘤学 | 4480篇 |
出版年
2024年 | 96篇 |
2023年 | 558篇 |
2022年 | 1447篇 |
2021年 | 2551篇 |
2020年 | 1659篇 |
2019年 | 1638篇 |
2018年 | 1840篇 |
2017年 | 1636篇 |
2016年 | 1987篇 |
2015年 | 2718篇 |
2014年 | 3195篇 |
2013年 | 3638篇 |
2012年 | 5258篇 |
2011年 | 5202篇 |
2010年 | 3299篇 |
2009年 | 2829篇 |
2008年 | 3574篇 |
2007年 | 3336篇 |
2006年 | 3033篇 |
2005年 | 2700篇 |
2004年 | 2106篇 |
2003年 | 1951篇 |
2002年 | 1588篇 |
2001年 | 1237篇 |
2000年 | 1027篇 |
1999年 | 714篇 |
1998年 | 335篇 |
1997年 | 245篇 |
1996年 | 208篇 |
1995年 | 158篇 |
1994年 | 174篇 |
1993年 | 118篇 |
1992年 | 206篇 |
1991年 | 196篇 |
1990年 | 206篇 |
1989年 | 166篇 |
1988年 | 148篇 |
1987年 | 145篇 |
1986年 | 134篇 |
1985年 | 100篇 |
1984年 | 69篇 |
1983年 | 60篇 |
1982年 | 50篇 |
1981年 | 54篇 |
1980年 | 31篇 |
1979年 | 44篇 |
1978年 | 32篇 |
1977年 | 26篇 |
1975年 | 23篇 |
1970年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
Oswens Siu Hung Lo Wai Lun Law Hok Kwok Choi Yee Man Lee Judy Wai Chu Ho Chi Leung Seto 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2007,392(2):173-178
OBJECTIVES: The study aimed to review the etiologies of patients who underwent surgery for small bowel obstruction (SBO) and to evaluate the risk factors affecting the early postoperative outcomes. MATERIALS AND METHODS: A case series of 430 patients (252 men) with a mean age of 64.5 years, who underwent 437 operations for SBO, were retrospectively reviewed. RESULTS: Peritoneal adhesions and hernia were the most common causes of SBO, contributing 42.3 and 26.8% of all cases, respectively. Strangulation occurred in 27.7% and caused nonviable bowel in 13.0% of obstructing episodes. Old age (age >/= 70 years), female patient, nonadhesive obstruction, and hernia were the independent significant factors associated with bowel strangulation. The 30-day mortality was 6.5%, and the median postoperative hospital stay was 8 days. Old age, the presence of premorbid pulmonary disease, and malignant obstruction were the independent factors associated with operative mortality. The overall complication rate was 35.5%, and old age was the only significant factor associated with postoperative complications. CONCLUSIONS: Surgery for SBO is still associated with significant mortality and morbidity. As old age is significantly associated with an increased incidence of strangulation, operative mortality, and complications, this group of patients should be managed with extra cautions to avoid unfavorable outcome of surgery. 相似文献
52.
53.
苄丙酮香豆素对实验性大鼠肾草酸钙结石形成的影响 总被引:1,自引:0,他引:1
目的:探讨Vit.K拮抗剂苄丙酮香豆素(商品名华法令)对大鼠肾草酸钙结石形成的影响。方法:采用乙二醇饮水和氯化铵灌胃作成石剂,30只Wistar大鼠随机分为对照组(A组)、成石组(B组)、华法令组(C组)。饲养4周后,检测大鼠肾组织钙含量和草酸钙晶体形成、24h尿钙、尿草酸含量及血生化指标。结果:成石组和华法令组肾组织中钙、镁含量,24h尿草酸及尿钙、镁排泄量差异无显著性意义;镜下观察发现:华法令组大鼠肾脏草酸钙结晶形成多于成石组,但组间比较差异无显著性意义。结论:苄丙酮香豆素对大鼠肾草酸钙结石的形成无显著影响。 相似文献
54.
Sa-Yoon Kang Jung Seok Lee Jay Chol Choi Ji-Hoon Kang 《JOURNAL OF CLINICAL NEUROLOGY》2007,3(3):158-160
A small proportion of thymoma patients without myasthenia gravis (MG) have been observed to develop MG after total removal of the thymoma. However, the underlying cause is not yet known due to the rarity of postoperative MG patients. We report a 39-year-old man in whom MG appeared after surgical removal of a thymoma. Computed tomography and magnetic resonance imaging showed no signs of recurrent or metastatic thymoma. Administration of pyridostigmine bromide resulted in the prompt improvement of myasthenic symptoms. Our observations indicate that postoperative follow-up care with monitoring of possible postoperative MG is necessary after resecting a thymoma. 相似文献
55.
56.
应用前列腺素E1注射治疗勃起功能障碍8年经验 总被引:1,自引:0,他引:1
目的观察前列腺素E1(PGE1)注射治疗勃起功能障碍(ED)的长期疗效、副作用及预后。方法使用PGE1行阴茎海绵体注射,阴茎硬度检查仪(Rigiscan)连续记录1h,并根据观察结果,调查PGE1注射剂量,确定每例患者合适的注射量,掌握注射方法后回家自行注射。共筛选出ED患者410例,随访患者阴茎勃起情况、药量调整和副作用。结果410例ED患者中,心理性139例,静脉性83例,动脉性36例,神经性78例,混合性74例。对治疗满意的患者有256例(62.44%),其中21例(5.1%)在使用PGE15次后停用,并能达到满意的性生活而治愈。293例(71.46%)患者自述注射时有胀痛感。171例(43.17%)因疼痛(105例)、操作不便(25例)、副作用顾虑(37例)和其他原因(4例)而于6个月后放弃治疗。204例(49.76%)患者使用时间已超过1年,24例(5.85%)患者使用时间已超过5年,7例(1.7%)使用已有8年。未发现阴茎异常勃起和阴茎海绵体纤维化。注射损伤阴茎表面血管致瘀斑者有20例。有27例患者失访。结论PGE1是治疗ED的一种安全有效的药物,可以长期使用。其最常见的副作用是阴茎疼痛。Rigiscan能帮助确定PGE1的注射剂量。 相似文献
57.
Su Jin Lee Young Keun On Eun Jeong Lee Joon Young Choi Byung-Tae Kim Kyung-Han Lee 《Journal of nuclear medicine》2008,49(8):1277-1282
Vascular 18F-FDG uptake marker represents inflammation in atherosclerotic lesions, but whether inflammation can be reversed by risk-modifying interventions has not, to our knowledge, been demonstrated. In this study, we evaluated the change of vascular 18F-FDG uptake in response to lifestyle intervention on serial PET/CT scans and further assessed how the findings relate to atherogenic risk reduction. METHODS: A total of 60 healthy adults underwent 18F-FDG PET/CT scans and atherogenic risk-factor assessment at baseline and again after 17.1 +/- 8.3 mo of practicing lifestyle modification. The PET/CT images were evaluated for the presence of vascular 18F-FDG lesions, and vessel-to-blood-pool 18F-FDG ratios were measured. Indices from summed ratios of positive lesions were compared and correlated to atherogenic risk factors. RESULTS: At follow-up, significant reductions in diastolic blood pressure (P < 0.05), total cholesterol (P < 0.05), and low-density lipoprotein level (P < 0.05) and an increase in high-density lipoprotein (HDL) level (P < 0.0001) were demonstrated. On the initial PET/CT scan, 50 of 60 subjects showed 1 or more 18F-FDG-positive lesions (5.9 +/- 5.0/subject), leading to a total of 352 vascular sites. On follow-up, 18F-FDG-positive lesions were significantly reduced to 2.1 +/- 2.2 sites per subject (P < 0.0001) and a total of 124 sites (64.8% reduction). Follow-up 18F-FDG-positive rates were significantly reduced for the aorta and iliac arteries. In addition, significant reductions in the whole-body 18F-FDG index from 1.39 +/- 1.23 to 0.53 +/- 0.59 (P < 0.0001) and carotid 18F-FDG index from 0.08 +/- 0.16 to 0.03 +/- 0.06 (P = 0.01) were shown. The whole-body 18F-FDG index correlated with total cholesterol (P < 0.05) and HDL level (P < 0.05), and the magnitude of reduction in the 18F-FDG index closely correlated to the amount of increase in plasma HDL level (P = 0.005). CONCLUSION: Our study demonstrated that vascular 18F-FDG uptake is reversed in response to atherogenic risk reduction by lifestyle intervention and that the magnitude of improvement correlates to increases in plasma HDL levels. Thus, serial 18F-FDG PET/CT may be useful for monitoring improvements in the inflammatory component of atherosclerotic lesions in response to risk modification. 相似文献
58.
Je-Yong Choi Hyung-Jong Kim Yong-Chan Lee Byoung-Ouck Cho Ha-Soo Seong Michael Cho Seong-Gon Kim 《Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics》2007,103(3):321-328
OBJECTIVE: Pamidronate has been studied as a therapeutic drug for various osteopenic diseases. However, avascular osteonecrosis in the jawbone has been recently reported in patients receiving pamidronate. The objective of this study was to examine the effect of pamidronate on bone regeneration in a controlled animal model. MATERIALS AND METHODS: To determine the effect of parmidronate on bone healing in a local bony defect area, a rabbit calvarial bony defect model was used and poly L-lactide-co-glycolide (PLGA) used as a drug carrier material. Four defect groups were made in each rabbit calvaria and the defects were treated as follows: untreated bony defect (group 1), PLGA only (group 2), 2 mg of pamidronate with PLGA (group 3), and 3 mg of pamidronate with PLGA (group 4). Bone healing was evaluated by radiography and histology at 1, 2, 4, 6, and 8 weeks after surgery. RESULTS: In radiographic analysis, radiopacity was lower in pamidronate groups than non-operated rabbit calvarial bone at all observation points (P < .05). In histological analysis, the initial bone formation at 1 week was not different among groups, but it was much lower in the pamidronate groups than in the control or PLGA group after 2 weeks. Newly formed bone at 1 week underwent avascular necrosis after 2 weeks in both pamidronate groups. Avascular necrosis was not observed until 8 weeks in both topically applied pamidronate groups. CONCLUSION: Collectively, pamidronate inhibits bone healing in rabbit calvarial bony defect and it may explain the avascular necrosis of the jaws in patients receiving pamidronate. 相似文献
59.
60.